Oppenheimer USA | OPY - Cash And Equivalent


Oppenheimer USA reported $38.29M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Bank Of America USD 239.32B 7.19B Dec/2025
Barclays GBP 235.35B 5.6B Mar/2026
BGC Partners USD 780.98M 70.52M Mar/2026
Canaccord Genuity CAD 1.67B 356.41M Dec/2025
Citigroup USD 349.58B 1.52B Dec/2025
Deutsche Bank EUR 149.87B 21.75B Mar/2026
Evercore Partners USD 985.99M 440.03M Mar/2026
Goldman Sachs USD 179.53B 15.27B Mar/2026
JPMorgan USD 343.34B 39.9B Dec/2025
Matsui Securities JPY 65.44B 1.93B Sep/2025
Moelis & Company USD 152.94M 355.65M Mar/2026
Morgan Stanley USD 133.53B 21.83B Mar/2026
Oppenheimer USA USD 38.29M 670K Sep/2025
Piper Sandler Companies USD 809.42M 695.42M Dec/2025
Prospect Capital USD 34.59M 3.47M Mar/2026
Raymond James Financial USD 11.22B 1.33B Mar/2026
Reinet Investments EUR 0 0 Mar/2023
Stifel Financial USD 2.9B 645.58M Mar/2026
Transnational Corp Of Nigeria NGN 25.17B 6.49B Sep/2025
UMB Financial USD 6.26B 1.51B Mar/2026
Wells Fargo USD 174.21B 139.41B Dec/2025
XP BRL 10.36B 2.06B Dec/2025